StockData
InMed Pharmaceuticals Inc. logo

InMed Pharmaceuticals Inc. (INM) shareholders

INMNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as MTRI
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/30
$1.37+0.05 (+3.44%)

Close on Oct 19, 2026Market cap $96.14MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
3M
Shares held, 13F filers
Institutional holders
20
13 new, 2 sold out
Net institutional buying
2M
In Q2 2026
Insider trades, 12 months
50 buys · 0 sales
Net bought $1.40M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Daniel Schneeberger
Joint filing with ADAR1 Capital Management, LLC (17.20%)
943,66817.20%13G (passive) amendmentSep 30, 2026
Vivo Opportunity Fund Holdings, L.P.
Joint filing with Vivo Opportunity, LLC (21.70%)
718,44421.70%13D (active)May 19, 2026
William Blank
Joint filing with Squadron Master Fund LP (9.80%), Squadron Capital Management LLC (9.80%) and 1 more
325,0009.80%13G (passive)May 19, 2026
Sabby Volatility Warrant Master Fund, Ltd.
Joint filing with Sabby Management, LLC (9.90%), Hal Mintz (9.90%)
280,1389.90%13G (passive)Dec 31, 2025
YA II PN, Ltd.
Joint filing with YA Global Investments II (U.S.), LP (9.99%), Yorkville Advisors Global, LP (9.99%) and 5 more
80,3729.99%13G (passive)Dec 13, 2024

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of INMValueChange% of portfolio
ADAR1 Capital Management, LLC800,000–$1.24MNew0.06%
Vivo Capital, LLC798,377–$1.24MNew0.11%
Squadron Capital Management LLC325,000–$503.75KNew0.16%
Ikarian Capital, LLC245,025–$379.79KNew0.04%
Ursa Fund Management, LLC125,800–$194.99KNew0.02%
Suvretta Capital Management, LLC100,000–$155.00KNew0.00%
Boothbay Fund Management, LLC74,244–$115.08KNew0.00%
Sabby Management, LLC44,970–$69.70K−175,2900.06%
Jane Street Group, LLC43,078–$66.77KNew0.00%
VR Adviser, LLC32,685–$50.66KNew0.00%
Citadel Advisors LLC26,084–$40.43K−20,8890.00%
Seven Grand Managers, LLC25,000–$38.75KNew0.00%
Scientech Research LLC15,461–$23.97KNew0.02%
Crestwood Advisors Group LLC14,900–$23.10KNew0.00%
Two Sigma Securities, LLC10,945–$16.97K−7,7730.00%
Stratos Wealth Partners, LTD.10,760–$16.68KNew0.00%
Private Wealth Management Group, LLC5,000–$7.75K–0.00%
SBI Securities Co., Ltd.300–$465–0.00%
Banque Cantonale Vaudoise6–$1.00M–0.00%
Federation des caisses Desjardins du Quebec2–$4–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares heldNew / addedReduced / closedShares boughtShares sold
Q2 2026203M13 / 03 / 23M0M
Q1 202690M4 / 20 / 20M0M
Q4 202570M3 / 01 / 40M0M
Q3 202590M5 / 10 / 30M0M
Q2 202570M2 / 10 / 00M0M
Q1 202550M2 / 01 / 20M0M
Q4 202450M5 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

1 funds held INM in Q2 2026, 0% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of INMValue% of fundAs of
Blackstone Alternative Multi-Strategy Fund6,495–$10.07K0.00%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares ownedLatest filing
Gregory J. DivisSee Remarks, Director–Nov 12, 2026
Eric A. AdamsPresident & CEO, Director58,894Dec 19, 2025
Jerad G. SeurerSee Remarks–Nov 12, 2026
Brett R. HagenSee Remarks–Nov 12, 2026
Netta JagpalChief Financial Officer–Dec 19, 2025
Eric C. HsuSr. VP, Pre-Clinical Res/Dev1,273Dec 19, 2025
Michael WoudenbergChief Operating Officer530Dec 19, 2025
Shane Aaron JohnsonSr VP & General Manager583,023Dec 19, 2025
Michelle Patricia PerniceDirector27,868Nov 12, 2026
Julianne BrunoDirector33,442Nov 12, 2026
Laura Lee SandlerDirector–Nov 12, 2026
Todd ShegogDirector–Nov 12, 2026
John Steven BatheryDirector–Dec 19, 2025
Nicole LemerondDirector–Dec 19, 2025
Neil A. KlompasDirector–Dec 19, 2025
Andrew HullDirector38,258Dec 19, 2025
Janet P. GroveDirector–Dec 23, 2024
Bryan T. BaldasareDirector–Dec 23, 2024
Tomas Kiselak10% owner–Nov 12, 2026
Peter Evan Harwin10% owner–Nov 12, 2026
Healthcare Fund II L.P. Fairmount10% owner–Nov 12, 2026
Funds Management LLC Fairmount10% owner10,555,507Nov 12, 2026
ADAR1 Capital Management, LLC10% owner98,297Nov 9, 2026
Daniel Schneeberger10% owner892,101Nov 9, 2026
Vivo Opportunity Cayman, LLC10% owner–Jul 16, 2026
Vivo Opportunity, LLC10% owner797,530Jul 16, 2026
Vivo Opportunity Fund Holdings, L.P.10% owner541,752Jul 16, 2026
Vivo Opportunity Cayman Fund, L.P.10% owner818,076Jul 16, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
ADAR1 Capital Management, LLC
10% owner
Nov 5, 2026Buy+2,640$13.10$34.57K98,297
ADAR1 Capital Management, LLC
10% owner
Oct 23, 2026Buy+4$1.32$5956,584
ADAR1 Capital Management, LLC
10% owner
Oct 19, 2026Buy+1,086$1.32$1.43K956,580
ADAR1 Capital Management, LLC
10% owner
Oct 16, 2026Buy+1$1.32$1955,494
ADAR1 Capital Management, LLC
10% owner
Oct 15, 2026Buy+984$1.32$1.30K955,493
ADAR1 Capital Management, LLC
10% owner
Oct 14, 2026Buy+8,021$1.33$10.67K954,509
ADAR1 Capital Management, LLC
10% owner
Oct 13, 2026Buy+564$1.33$750946,488
ADAR1 Capital Management, LLC
10% owner
Oct 8, 2026Buy+2,256$1.33$3.00K945,924
ADAR1 Capital Management, LLC
10% owner
Oct 7, 2026Buy+3,046$1.33$4.05K943,668
ADAR1 Capital Management, LLC
10% owner
Oct 6, 2026Buy+5,601$1.33$7.44K940,622
ADAR1 Capital Management, LLC
10% owner
Oct 5, 2026Buy+18,182$1.33$24.18K935,021
ADAR1 Capital Management, LLC
10% owner
Oct 2, 2026Buy+8,307$1.33$11.05K916,839
ADAR1 Capital Management, LLC
10% owner
Oct 1, 2026Buy+16,431$1.33$21.85K908,532
Daniel Schneeberger
10% owner
Sep 16, 2026Buy+8,340$1.29$10.76K892,101
Daniel Schneeberger
10% owner
Sep 15, 2026Buy+54,256$1.30$70.53K883,761
Daniel Schneeberger
10% owner
Sep 14, 2026Buy+28,505$1.29$36.77K829,505
Vivo Opportunity Cayman Fund, L.P.
10% owner
Jul 16, 2026Buy+19$1.55$29743,057
Vivo Opportunity Cayman Fund, L.P.
10% owner
Jul 16, 2026Buy+2$1.55$375,019
ADAR1 Capital Management, LLC
10% owner
Jul 15, 2026Buy+1,000$1.56$1.56K801,000
Vivo Opportunity Cayman Fund, L.P.
10% owner
Jul 15, 2026Buy+13,761$1.55$21.33K743,038
Vivo Opportunity Cayman Fund, L.P.
10% owner
Jul 15, 2026Buy+1,389$1.55$2.15K75,017
Vivo Opportunity Cayman Fund, L.P.
10% owner
Jul 14, 2026Buy+4,882$1.55$7.57K729,277
Vivo Opportunity Cayman Fund, L.P.
10% owner
Jul 14, 2026Buy+493$1.55$76473,628
Vivo Opportunity, LLC
10% owner
Jul 2, 2026Buy+1,460$1.55$2.26K724,395
Vivo Opportunity, LLC
10% owner
Jul 2, 2026Buy+147$1.55$22873,135
Vivo Opportunity, LLC
10% owner
Jul 1, 2026Buy+3,946$1.55$6.12K722,935
Vivo Opportunity, LLC
10% owner
Jul 1, 2026Buy+398$1.55$61772,988
Vivo Opportunity, LLC
10% owner
Jun 30, 2026Buy+55$1.54$8572,590
Vivo Opportunity, LLC
10% owner
Jun 30, 2026Buy+545$1.54$839718,989
Vivo Opportunity, LLC
10% owner
Jun 8, 2026Buy+29,518$1.52$44.87K718,444
Vivo Opportunity, LLC
10% owner
Jun 8, 2026Buy+2,982$1.52$4.53K72,535
Vivo Opportunity, LLC
10% owner
Jun 5, 2026Buy+5,045$1.57$7.92K69,553
Vivo Opportunity, LLC
10% owner
Jun 5, 2026Buy+49,966$1.57$78.45K688,926
Vivo Opportunity, LLC
10% owner
Jun 4, 2026Buy+618$1.57$97064,508
Vivo Opportunity, LLC
10% owner
Jun 4, 2026Buy+6,125$1.57$9.62K638,960
Vivo Opportunity, LLC
10% owner
Jun 3, 2026Buy+714$1.55$1.11K63,890
Vivo Opportunity, LLC
10% owner
Jun 3, 2026Buy+7,069$1.55$10.96K632,835
Vivo Opportunity, LLC
10% owner
Jun 2, 2026Buy+2,095$1.52$3.18K63,176
Vivo Opportunity, LLC
10% owner
Jun 2, 2026Buy+20,753$1.52$31.54K625,766
Vivo Opportunity, LLC
10% owner
Jun 1, 2026Buy+1,498$1.55$2.32K61,081
Vivo Opportunity, LLC
10% owner
Jun 1, 2026Buy+14,838$1.55$23.00K605,013
Vivo Opportunity, LLC
10% owner
May 29, 2026Buy+1,632$1.57$2.56K59,583
Vivo Opportunity, LLC
10% owner
May 29, 2026Buy+16,164$1.57$25.38K590,175
Vivo Opportunity, LLC
10% owner
May 21, 2026Buy+3,118$1.69$5.27K57,951
Vivo Opportunity, LLC
10% owner
May 21, 2026Buy+30,882$1.69$52.19K574,011
Vivo Opportunity, LLC
10% owner
May 20, 2026Buy+5,154$1.56$8.04K54,833
Vivo Opportunity, LLC
10% owner
May 20, 2026Buy+51,056$1.56$79.65K543,129
Daniel Schneeberger
10% owner
May 19, 2026Buy+200,000$1.50$300.00K800,000
Daniel Schneeberger
10% owner
May 19, 2026Buy+200,000$1.56$312.00K600,000
Daniel Schneeberger
10% owner
May 19, 2026Buy+68,551$1.60$109.68K400,000
Alexandra Diane Janet Mancini
–
Jul 31, 2024Sale−240$0.18$430
Andrew Hull
Director
Feb 21, 2024Buy+37,500$0.39$14.63K38,258
Eric A. Adams
President & CEO, Director
Feb 20, 2024Buy+41,600$0.36$14.98K43,959
Eric A. Adams
President & CEO, Director
Apr 14, 2022Buy+14,160$0.89$12.60K59,003
Eric A. Adams
President & CEO, Director
Apr 13, 2022Buy+8,560$0.85$7.28K44,843
Bruce Colwill
CFO
Jan 24, 2022Buy+5,000$1.09$5.45K11,515
Shane Aaron Johnson
SVP, GM of BayMedica LLC
Jan 6, 2022Buy+8,500$1.26$10.71K304,595
Shane Aaron Johnson
SVP, GM of BayMedica LLC
Dec 30, 2021Buy+8,093$1.33$10.76K296,095
Shane Aaron Johnson
SVP, GM of BayMedica LLC
Nov 15, 2021Buy+5,000$1.37$6.85K288,002
Eric A. Adams
President & CEO, Director
Sep 29, 2021Buy+8,800$1.73$15.22K36,283

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
+855.8%
From 0M shares
Short volume, 20 days
47.1%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of InMed Pharmaceuticals's stock actually held short. Settlement fails (shares not delivered on time) peaked at 36,285 shares on Sep 4, 2026 over the last 90 days.

See a number that looks wrong?